Claims for obesity drugs increased 42% in 2023, 92% since 2020: report
The use of obesity medications among Canadian employer-sponsored benefits plan members has grown substantially, with claims increasing 42 per cent in 2023 and roughly 92 per cent since 2020, according to a new report by Manulife Financial Corp. The report, based on aggregate claims data, found more women are using obesity drugs than men (79 […]
- June 7, 2024 June 6, 2024
- 09:00